Upcoming Presentations
Date
Presentation
Webcast
Registration
19th March 2024
Results of LEGEND Phase IIa combination trial with lanifibranor and empagliflozin in patients with MASH/NASH and T2D
Latest Presentations
Date
Presentation
Webcast
Registration